Skip to main content

Table 4 Determinants of treatment with antifibrotic drugs, logistic regression analysis during the study period (January 2014 – December 2016)

From: Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries

Variable

ODDS RATIO

95%CI

p

Female gender

0.76

0.39–1.48

0.419

Age at inclusion

0.98

0.95–1.02

0.413

FVCa, % predicted

0.96

0.93–1.00

0.024

FEV1b, % predicted

1

0.97–1.04

0.744

DLCOc, % predicted

0.98

0.96–1.01

0.171

Country

 Finland

1

 

< 0.0001

 Sweden

5.48

2.65–11.33

Type of Hospital

 Peripheral

1

 

0.503

 University

1.27

0.63–2.57

  1. Definitions on abbreviations: aFEV1 Forced expiratory volume; bFVC Forced vital capacity; cDLCO Diffusing capacity of carbon monoxide
Back to article page

Multidisciplinary Respiratory Medicine

ISSN: 2049-6958

Contact us